Advances in antiviral drug design. Volume 3

被引:0
|
作者
Kelly, Terence A.
机构
来源
| 1600年 / ACS, Washington, DC, USA卷 / 122期
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Knowledge-based potentials in drug design.
    Dominy, BN
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U36 - U36
  • [32] Shape-based denovo drug design.
    Wipke, WT
    Wang, Z
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : U498 - U498
  • [33] Shape signatures and receptor based drug design.
    Tian, LF
    Zauhar, RJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U528 - U529
  • [34] RAPID: Randomized pharmacophore identification for drug design.
    Finn, PW
    Kavraki, LE
    Latombe, JC
    Motwani, R
    Shelton, C
    Venkatasubramanian, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 95 - COMP
  • [35] Free energy calculations in rational drug design.
    McCammon, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U896 - U896
  • [36] Catalytic chelators: Mechanism and implications for drug design.
    Chong, CR
    Auld, DS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U212 - U212
  • [37] Protein family clustering as an aid to drug design.
    Sitkoff, DF
    Krystek, SR
    Bassolino, DA
    Cheney, DL
    Davis, ME
    Loughney, D
    Mason, JS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U425 - U425
  • [38] New reagents, reactions, and peptidomimetics for drug design.
    Goodman, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U75 - U76
  • [39] Discovery of risedronate: An interdisciplinary approach in drug design.
    Zurich, ML
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U34 - U34
  • [40] Catalytic chelators: Mechanism and implications for drug design.
    Chong, CR
    Auld, DS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U833 - U833